In this new and exciting article we capture the journey of two public-listed company - iX Biopharma and ASLAN Pharmaceuticals, listed on SGX and Nasdaq respectively in a series of questions and answers. Hear what Ms Eva Tan, Director of Corporate and Commercial Strategy at iX Biopharma and Dr. Carl Firth, founder and CEO of ASLAN Pharmaceuticals have to say about their journey going public, and how start-ups can undertake this path successfully. By Shainan Hora

By Esther Sang Myung Han

Contributed by: Zheng-Shan Chong.

What is a shareholders' agreement, why is it important, and what does it need to contain? Faith Sing of fsLAW demystifies the function and contents of a shareholders' agreement, and offers tips on what you need to know when starting your new venture.

Who decides which biotech startups get funded? Investment managers combine scientific expertise with business acumen to get the biggest bang for their buck. by: Zheng-Shan Chong and Shainan Hora

Companies are always on the lookout for interesting new technologies that can value-add their business. Who scouts for these breakthroughs? Introducing - the alliance manager. Contributed by: Zheng-Shan Chong and Shweta Jadhav

What constitutes a good investment and what attracts investors to fund companies in the healthcare space? BCS interviewed Dr. Jessie Tong, Senior Manager at SGInnovate Venture Investing team and Dr. Koh Fong Ming, Senior Associate at Heritas Capital Management, to provide a peek into the fundraising process and to discuss insights to help start-ups in their fundraising journey. Contributed by: Shainan Hora.